Literature DB >> 9769419

Regulation of murine cystic fibrosis transmembrane conductance regulator Cl- channels expressed in Chinese hamster ovary cells.

K A Lansdell1, J F Kidd, S J Delaney, B J Wainwright, D N Sheppard.   

Abstract

1. We investigated the effect of protein kinases and phosphatases on murine cystic fibrosis transmembrane conductance regulator (CFTR) Cl- channels, expressed in Chinese hamster ovary (CHO) cells, using iodide efflux and the excised inside-out configuration of the patch-clamp technique. 2. The protein kinase C (PKC) activator, phorbol dibutyrate, enhanced cAMP-stimulated iodide efflux. However, PKC did not augment the single-channel activity of either human or murine CFTR Cl- channels that had previously been activated by protein kinase A. 3. Fluoride, a non-specific inhibitor of protein phosphatases, stimulated both human and murine CFTR Cl- channels. However, calyculin A, a potent inhibitor of protein phosphatases 1 and 2A, did not enhance cAMP-stimulated iodide efflux. 4. The alkaline phosphatase inhibitor, (-)-bromotetramisole augmented cAMP-stimulated iodide efflux and, by itself, stimulated a larger efflux than that evoked by cAMP agonists. However, (+)-bromotetramisole, the inactive enantiomer, had the same effect. For murine CFTR, neither enantiomer enhanced single-channel activity. In contrast, both enantiomers increased the open probability (Po) of human CFTR, suggesting that bromotetramisole may promote the opening of human CFTR. 5. As murine CFTR had a low Po and was refractory to stimulation by activators of human CFTR, we investigated whether murine CFTR may open to a subconductance state. When single-channel records were filtered at 50 Hz, a very small subconductance state of murine CFTR was observed that had a Po greater than that of human CFTR. The occupancy of this subconductance state may explain the differences in channel regulation observed between human and murine CFTR.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9769419      PMCID: PMC2231228          DOI: 10.1111/j.1469-7793.1998.751bd.x

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  43 in total

1.  Levamisole inhibits intestinal Cl- secretion via basolateral K+ channel blockade.

Authors:  E C Mun; J M Mayol; M Riegler; T C O'Brien; O C Farokhzad; J C Song; C Pothoulakis; B J Hrnjez; J B Matthews
Journal:  Gastroenterology       Date:  1998-06       Impact factor: 22.682

2.  The substituted benzimidazolone NS004 is an opener of the cystic fibrosis chloride channel.

Authors:  V K Gribkoff; G Champigny; P Barbry; S I Dworetzky; N A Meanwell; M Lazdunski
Journal:  J Biol Chem       Date:  1994-04-15       Impact factor: 5.157

3.  Regulation of the gating of cystic fibrosis transmembrane conductance regulator C1 channels by phosphorylation and ATP hydrolysis.

Authors:  T C Hwang; G Nagel; A C Nairn; D C Gadsby
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

4.  Coupling of CFTR Cl- channel gating to an ATP hydrolysis cycle.

Authors:  T Baukrowitz; T C Hwang; A C Nairn; D C Gadsby
Journal:  Neuron       Date:  1994-03       Impact factor: 17.173

5.  cAMP-dependent protein kinase-mediated phosphorylation of cystic fibrosis transmembrane conductance regulator residue Ser-753 and its role in channel activation.

Authors:  F S Seibert; J A Tabcharani; X B Chang; A M Dulhanty; C Mathews; J W Hanrahan; J R Riordan
Journal:  J Biol Chem       Date:  1995-02-03       Impact factor: 5.157

6.  The two nucleotide-binding domains of cystic fibrosis transmembrane conductance regulator (CFTR) have distinct functions in controlling channel activity.

Authors:  M R Carson; S M Travis; M J Welsh
Journal:  J Biol Chem       Date:  1995-01-27       Impact factor: 5.157

7.  Regulation of the cystic fibrosis transmembrane conductance regulator Cl- channel by specific protein kinases and protein phosphatases.

Authors:  H A Berger; S M Travis; M J Welsh
Journal:  J Biol Chem       Date:  1993-01-25       Impact factor: 5.157

8.  Effect of ATP concentration on CFTR Cl- channels: a kinetic analysis of channel regulation.

Authors:  M C Winter; D N Sheppard; M R Carson; M J Welsh
Journal:  Biophys J       Date:  1994-05       Impact factor: 4.033

9.  Phosphatase inhibitors activate normal and defective CFTR chloride channels.

Authors:  F Becq; T J Jensen; X B Chang; A Savoia; J M Rommens; L C Tsui; M Buchwald; J R Riordan; J W Hanrahan
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

10.  Functionally distinct phospho-forms underlie incremental activation of protein kinase-regulated Cl- conductance in mammalian heart.

Authors:  T C Hwang; M Horie; D C Gadsby
Journal:  J Gen Physiol       Date:  1993-05       Impact factor: 4.086

View more
  24 in total

1.  The H-loop in the second nucleotide-binding domain of the cystic fibrosis transmembrane conductance regulator is required for efficient chloride channel closing.

Authors:  Monika Kloch; Michał Milewski; Ewa Nurowska; Beata Dworakowska; Garry R Cutting; Krzysztof Dołowy
Journal:  Cell Physiol Biochem       Date:  2010-01-12

2.  Partial rescue of F508del-cystic fibrosis transmembrane conductance regulator channel gating with modest improvement of protein processing, but not stability, by a dual-acting small molecule.

Authors:  Jia Liu; Hermann Bihler; Carlos M Farinha; Nikhil T Awatade; Ana M Romão; Dayna Mercadante; Yi Cheng; Isaac Musisi; Walailak Jantarajit; Yiting Wang; Zhiwei Cai; Margarida D Amaral; Martin Mense; David N Sheppard
Journal:  Br J Pharmacol       Date:  2018-02-22       Impact factor: 8.739

Review 3.  Airway hydration and COPD.

Authors:  Arunava Ghosh; R C Boucher; Robert Tarran
Journal:  Cell Mol Life Sci       Date:  2015-06-12       Impact factor: 9.261

4.  Hematopoietic stem/progenitor cells express functional mitochondrial energy-dependent cystic fibrosis transmembrane conductance regulator.

Authors:  Donatella Piro; Claudia Piccoli; Lorenzo Guerra; Francesca Sassone; Annamaria D'Aprile; Maria Favia; Stefano Castellani; Sante Di Gioia; Silvia Lepore; Maria Luisa Garavaglia; Teresa Trotta; Angela Bruna Maffione; Valeria Casavola; Giuliano Meyer; Nazzareno Capitanio; Massimo Conese
Journal:  Stem Cells Dev       Date:  2011-06-20       Impact factor: 3.272

5.  Human-mouse cystic fibrosis transmembrane conductance regulator (CFTR) chimeras identify regions that partially rescue CFTR-ΔF508 processing and alter its gating defect.

Authors:  Qian Dong; Lynda S Ostedgaard; Christopher Rogers; Daniel W Vermeer; Yuping Zhang; Michael J Welsh
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-30       Impact factor: 11.205

6.  CFTR potentiators partially restore channel function to A561E-CFTR, a cystic fibrosis mutant with a similar mechanism of dysfunction as F508del-CFTR.

Authors:  Yiting Wang; Jia Liu; Avgi Loizidou; Luc A Bugeja; Ross Warner; Bethan R Hawley; Zhiwei Cai; Ashley M Toye; David N Sheppard; Hongyu Li
Journal:  Br J Pharmacol       Date:  2014-09-05       Impact factor: 8.739

7.  Bestrophin expression and function in the human pancreatic duct cell line, CFPAC-1.

Authors:  Laura L Marsey; John P Winpenny
Journal:  J Physiol       Date:  2009-02-23       Impact factor: 5.182

8.  Impact of the F508del mutation on ovine CFTR, a Cl- channel with enhanced conductance and ATP-dependent gating.

Authors:  Zhiwei Cai; Timea Palmai-Pallag; Pissared Khuituan; Michael J Mutolo; Clément Boinot; Beihui Liu; Toby S Scott-Ward; Isabelle Callebaut; Ann Harris; David N Sheppard
Journal:  J Physiol       Date:  2015-04-09       Impact factor: 5.182

9.  A kinase-regulated mechanism controls CFTR channel gating by disrupting bivalent PDZ domain interactions.

Authors:  Viswanathan Raghuram; Hayley Hormuth; J Kevin Foskett
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-24       Impact factor: 11.205

10.  State-dependent modulation of CFTR gating by pyrophosphate.

Authors:  Ming-Feng Tsai; Hiroyasu Shimizu; Yoshiro Sohma; Min Li; Tzyh-Chang Hwang
Journal:  J Gen Physiol       Date:  2009-04       Impact factor: 4.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.